Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2989
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHUYS, J-
dc.contributor.authorVAN DEN BERGHE, G-
dc.contributor.authorFREYENSt, P-
dc.contributor.authorKAYIHIGIf, J-
dc.date.accessioned2024-10-03T13:02:10Z-
dc.date.available2024-10-03T13:02:10Z-
dc.date.issued1976-
dc.identifier.citationAfr. J. Med. med. Sci. (1976)5, 75-77en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2989-
dc.descriptionARTICLEen_US
dc.description.abstractThe authors communicate their experience in the treatment of ankylostomiase with levamisole; with a dose of 2-5 mg/kg body weight they achieved a positive result in two-thirds of the cases in a series of 119 without any toxic side effectsen_US
dc.description.sponsorshipCOLLEGE OF MEDICINEen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINEen_US
dc.subjectankylostomiaseen_US
dc.subjectlevamisoleen_US
dc.subjectdoseen_US
dc.subjecttoxicen_US
dc.titleTreatment of ankylostomiasis with levamisoleen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Huys et al_Treatment_1976.pdfARTICLE3.11 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.